INS and metabolic dysfunction-associated steatotic liver disease: The greatest insulin reduction was observed for patients whose indication for transplant was ArLD (36.28 ± 9.9 units/day; 59% reduction) and NAFLD (32.4 ± 7.9 units/day; 45.5% reduction).